-
Signature
-
/s/ Charles Mosseri-Marlio
-
Issuer symbol
-
NVCT
-
Transactions as of
-
23 Oct 2025
-
Net transactions value
-
+$957,083
-
Form type
-
4
-
Filing time
-
29 Oct 2025, 08:00:22 UTC
Quoteable Key Fact
"Marlio Charles Mosseri filed Form 4 for Nuvectis Pharma, Inc. (NVCT) on 29 Oct 2025."
Quick Takeaways
- This page summarizes Marlio Charles Mosseri's Form 4 filing for Nuvectis Pharma, Inc. (NVCT).
- 3 reported transactions and 0 derivative rows are listed below.
- Filing timestamp: 29 Oct 2025, 08:00.
What Changed
- Previous filing in this sequence was filed on 24 Jun 2025.
- Current net transaction value: +$957,083.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Mosseri Marlio Charles |
10%+ Owner |
27 RIPPLEVALE GROVE, LONDON, LIBYAN ARAB JAMAHIRIYA |
/s/ Charles Mosseri-Marlio |
29 Oct 2025 |
0001806384 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
NVCT |
Common Stock |
Purchase |
$284,214 |
+46,900 |
+1.6% |
$6.06 |
3,028,706 |
23 Oct 2025 |
By Emerald Hill Ventures SARL SPF. |
F1 |
| transaction |
NVCT |
Common Stock |
Purchase |
$215,459 |
+35,034 |
+1.2% |
$6.15 |
3,063,740 |
24 Oct 2025 |
By Emerald Hill Ventures SARL SPF. |
F1 |
| transaction |
NVCT |
Common Stock |
Purchase |
$457,410 |
+72,836 |
+2.4% |
$6.28 |
3,136,576 |
27 Oct 2025 |
By Emerald Hill Ventures SARL SPF. |
F1 |
| holding |
NVCT |
Common Stock |
|
|
|
|
|
109,321 |
23 Oct 2025 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses: